Jonathan Hempel is a Senior Scientific Lead in Early Molecule Discovery at Eli Lilly and Company since 2024, bringing a decade of experience in the pharmaceutical industry. Previously, they served as a Principal Scientist II at Novartis Institutes for BioMedical Research from 2020 to 2024, and held various roles at Vanderbilt University and its Medical Center, including an American Heart Association Postdoctoral Research Fellowship. Jonathan completed a Bachelor of Science in Chemistry and Economics from the University of Richmond and earned a Ph.D. in Organic Chemistry from Vanderbilt University.
Location
Louisville, United States
This person is not in any teams
This person is not in any offices